SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (53717)4/9/2014 11:16:15 AM
From: Jurgis Bekepuris  Read Replies (3) of 78570
 
CE: Looks like 2013 might have been a difficult (bad) year for CE
I am not sure how you can claim that. Their income before the extraordinary gain is very similar to 2011 and 2012. So either all these years were bad or it's trading at high valuation to the earnings in 2011 and 2012 and before-extraordinary-gain-2013.

I never use forward P/E and I hope you don't seriously use it either.

All these chemical companies have the same products. BASFY, EVK.DE. They just claim some "proprietary" stuff like every insurance company claims "the best" software and people. I think BASFY trades at better valuation than CE. I would not buy it here either though.

Your call and your money though. I would not touch this one at current valuation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News